Neurology Archives

UNC School of Medicine researchers, led by Ian Shih, PhD, associate professor of Neurology and Biomedical Research Imaging Center, developed an improved fiber-based optical method to measure activity changes in the brain.

UNC Lineberger's Chad V. Pecot, MD, published a paper that found inflammatory monocytes, immune cells that build clots to promote wound healing, also make it possible for tumor cells to migrate to other parts of the body.

Chad Pecot, MD, associate professor of medicine and member of the UNC Lineberger Comprehensive Cancer Center, will lead the new center dedicated to the investigation of the many roles of RNA in health and disease.

Read the latest news from the UNC Department of Neurology.

James F. Howard, MD, Distinguished Professor of Neuromuscular Disease, Professor of Neurology, Medicine and Allied Health in the UNC School of Medicine, was lead investigator in the Phase 3 clinical trial of zilucoplan.

James F. Howard, Jr, MD, in the UNC Department of Neurology is the lead primary investigator in the CHAMPION-MG trial for Ultomiris (ravulizumab-cwvz) as a treatment for adults with generalised myasthenia gravis who are anti-acetylcholine receptor antibody-positive, which represents 80% of people living with the disease.

UNC School of Medicine researchers led by Ian Shih, PhD, used fMRI and a genetic mouse model to study the effects of a neurotransmitter on brain network functional connectivity, a dynamic process crucial for human health and behavior.

James F. Howard Jr., MD, professor in the UNC Department of Neurology, was principal investigator of the ADAPT+ trial for the experimental drug efgartigimod, developed by Belgian pharmaceutical company Argenx.

The department's spring newsletter includes stories on the UNC COVID Recovery Clinic, views from the new Acute Inpatient Rehab center in Hillsborough, and new faculty members and advanced practice providers.

Ana C. G. Felix, MBBCh, FAAN, has been elected as the American Academy of Neurology's 2022-2023 Vice Chair of the AB Baker Section on Neurological Education.

Robert Statts will begin his work in the interim role on March 17.

James F. Howard Jr., MD, professor in the UNC Department of Neurology, was lead investigator in UCB's RAISE trial to evaluate zilucoplan as a treatment for generalized myasthenia gravis in adults.

Robert Smith III, PhD, currently is associate chair for administration in the Department of Neurology. He will begin his new role on Feb. 28.

Category: Neurology

Scientists Develop New Method for Improved Fiber Optic Measurement of Brain Activity Changes

UNC Lineberger Creates RNA Discovery Center

UNC Neurology’s May 2022 Newsletter is Out

UCB Presents Efficacy, Safety Results for Zilucoplan, Rozanolixizumab for Generalized Myasthenia Gravis

FDA Approves Treatment for Myasthenia Gravis After Phase III Study Led by James Howard, MD

Scientists Detail Brain Dynamics Implicated in Neurological Conditions

Interim Data Suggest Long-term Treatment with VYVGART Provides Improvement in Generalized Myasthenia Gravis Disease Scores

UNC Physical Medicine and Rehabilitation Spring Newsletter is Out

Felix Elected to AAN Section Leadership

Statts Named Department of Neurology Interim Associate Chair for Administration

Phase 3 Study Results Show Positive Data in Treatment of Myasthenia Gravis with Zilucoplan

Smith Named Vice Dean of the UNC Gillings School of Global Public Health